BioCentury
ARTICLE | Clinical News

Topsalysin: Preliminary Phase IIa data

February 8, 2016 8:00 AM UTC

Preliminary data from 7 patients in an open-label, U.K. Phase IIa trial showed that a single intraprostatic injection of topsalysin led to 1 complete ablation of the tumor at 6 months. Additionally, 3...